Retail
Crocs Tries To Lure Athletes; New Line, Same Look (CROX)
Published:
Last Updated:
Crocs, Inc. (NASDAQ: CROX) is one of the brands that has come at-risk over its future. The company is also flying under the “going concern” flag from auditors. And now it is bringing a new line of shoe for athletic recovery called the “Prepair” designed to help athletes recover following fitness and athletic events. This line is said to be specifically designed to improve recovery time for recreational and professional athletes alike.
The inside of these shoes comes with the Croslite™ material formulation with an anti-bacterial and anti-fungal silver additive to help keep feet healthy. The company claims one study showed that this took off 50% of the reduction in peak pressures, as well as a reduction in peak muscular efforts.
Crocs has set a manufacturer’s suggested retail price of $34.99 for a slide or flip-flop version of the Crocs, or $39.99 for the clog version. Maybe comfort can trump ugliness in a new sales effort. On a personal note and an observation of a former hi-flier, we’d guess that athletes may choose to have their feet hurt over buying these. But we’d also admit the surprise and dismay of just how well these sold before 2008.
The good news is that Crocs stock has recovered about 200% from recent lows, but the bad news is that the $2.29 price is down from a 52-week high of $12.50. Two years ago, this stock was exponentially higher than that 52-week high.
JON C. OGG
Want retirement to come a few years earlier than you’d planned? Or are you ready to retire now, but want an extra set of eyes on your finances?
Now you can speak with up to 3 financial experts in your area for FREE. By simply clicking here you can begin to match with financial professionals who can help you build your plan to retire early. And the best part? The first conversation with them is free.
Click here to match with up to 3 financial pros who would be excited to help you make financial decisions.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.